Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of C.Diff in Patients With a Diagnosis of a Lower Respiratory Tract Infection

NCT02563106 is registered in ClinicalTrials.gov with Theriva Biologics, Inc. as lead sponsor.

NCT NCT02563106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02563106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of C.Diff in Patients With a Diagnosis of a Lower Respiratory Tract Infection
Lead sponsor
Theriva Biologics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
November 30, 2016
Enrollment
413 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, clostridium infections